Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer

Strahlentherapie und Onkologie

Volumn 182, Issue 1, 2006, Pages 22-29

  Roddiger, Sandra J ^a   Kolotas, Christos ^b   Filipowicz, Ineza ^a   Kurek, Ralf ^a   Kuner, Ralph Paul ^c   Martin, Thomas ^d   Baltas, Dimos ^a   Rogge, Bernd ^a   Kontova, Marina ^a   Hoffmann, Gerald ^c   Pollow, Bettina ^c   Zamboglou, Nikolaos ^a  

^a Klinikum Offenbach   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c ST JOSEFS HOSPITAL   (Germany)

^d KLINIKUM BREMEN MITTE   (Germany)

Author keywords

Breast cancer; Interstitial HDR brachytherapy; Neoadjuvant treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; BREAST FIBROSIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; SYSTEMIC THERAPY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOSE FRACTIONATION; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK FACTORS; TAXOIDS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 30344433253     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1454-7     Document Type: Article

References (46)

1. Amat S, Bougnoux P, Penault-Llorca F, et al. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer 2003;88:1339-45.
2. Aryus B, Audretsch W, Gogolin F, et al. Remission rates following preoperative chemotherapy and radiation therapy in patients with breast cancer. Strahlenther Onkol 2000;176:411-5.
3. Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast conserving surgery. Int J Radiat Oncol Biol Phys 2001;50:1003-11.
4. Baldini E, Gardin G, Evangelista G, et al. Long-term results of combined-modality therapy for inflammatory breast carcinoma. Clin Breast Cancer 2004;5:358-63.
5. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-45.
6. Cance WG, Carey LA, Calvo BF, et al. Long-term outcome of neoadjuvant therapy for LABC: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 2002;236:295-302.
7. Clark J, Roseman J, Cance W, et al. Extending the indication for breast conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys 1998;42:345-50.
8. Colleoni M, Nole F, Minchella I, et al. Pre-operative chemotherapy and radiotherapy in breast cancer. Eur J Cancer 1998;34:641-5.
9. De Lena M, Varini M, Zucali R, et al. Multimodal treatment for locally advanced breast cancer. Results of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 1981;4:229-36.
10. Erol K, Baltali E, Altundag K, et al. Neoadjuvant chemotherapy with cyclo-phosphamide, mitoxantrone, and 5 FU in LABC. Onkologie 2005;28:81-5.
11. Ezzat AA, Ibrahim EM, Ajarim DS. High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin. Breast Cancer Res Treat 2000;62:237-44.
12. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project - B18. J Clin Oncol 1997;15:2483-93.
13. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85.
14. Fornasiero A, Ghiotto C, Daniele O, et al. Neoadjuvant moderatly high-dose chemotherapy with rh-G-CSF in locally advanced breast carcinoma. Tumori 2001;87:223-8.
15. Gerlach B, Audretsch W, Gogolin F, et al. Remission rates in breast cancer with preoperative chemotherapy and radiotherapy. Strahlenther Onkol 2003;179:306-11.
16. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988;62:2507-16.
17. Hutcheon AW, Heys SD, Sarkar TK, and the Aberdeen Breast Group. Neoadjuvant docetaxel in locally advanced breast cancer. Breast Cancer Res Treat 2003;79:Suppl 1:19-24.
18. Kolotas C, Zamboglou N. Role of interstitial brachytherapy in the treatment of malignant disease. Onkologie 2001;24:222-8.
19. Macchiavelli MR, Romero AO, Perez JE, et al. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am 1998;4:125-31.
20. Major T, Fodor J, Takacsi-Nagy Z et al. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality. Strahlenther Onkol 2005;181:89-96.
21. Makris A, Powles TJ, Ashley SE, et al. A reduction in the requirements for mastectomy in a randomised trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998;9:1151-4.
22. Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 2005;97:188-94.
23. Mauriac L, Durand M, Avril A, et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Ann Oncol 1991;2:347-54.
24. Merajver SD, Weber BL, Cody R, et al. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. J Clin Oncol 1997;15:2873-81.
25. Minckwitz G von, Raab G, Schuette M, et al. Dose-dense versus sequential adriamycin/docetaxel combination as preoperative chemotherapy in operable breast cancer (T2-3,N0-2,M0) - primary endpoint analysis of the GEPARDUO-study. Proc Am Soc Clin Oncol 2002;21:43a.abstract 168.
26. Morell LE, Lee YJ, Hurley J, et al. A phase II trial of neoadjuvant methothrexate, vinblastine, doxorubicine and cisplatin in the treatment of patients with locally advanced breast carcinoma. Cancer 1998;82:503-11.
27. Newman LA. Management of patients with locally advanced breast cancer. Curr Oncol Rep 2004;6:53-61.
28. Ott OJ, Potter R, Hammer J, et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy: preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol 2004; 180:642-9.
29. Ott OJ, Schulz-Wendtland R, Uter W, et al. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. Strahlenther Onkol 2005;181:638-44.
30. Polgar C, Fodor J, Major T, et al. The role of boost irradiation in the conservative treatment of stage I-II breast cancer. Pathol Oncol Res 2001;7:241-50.
31. Polgar C, Fodor J, Major T, et al. Is boost irradiation with interstitial brachytherapy less favourable than with teletherapy after breast conserving surgery? Eur J Obstet Gynecol Reprod Biol 2002;94:255-6.
32. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer. Strahlenther Onkol 2002;178:615-23.
33. Rouzier R, Mathieu MC, Sideris L, et al. Breast conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Cancer 2004;101:918-25.
34. Sauer G, Strnad V, Kurzeder C, et al. Partial breast irradiation after breast-conserving surgery. Strahlenther Onkol 2005;181:1-8.
35. Sauer R, Becker H, Hohenberger W, et al., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
36. Schwartz GF, Birchansky CA, Karmanicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.
37. Sehlen S, Hollenhorst H, Schymura B, et al. Psychosocial stress in cancer patients during and after radiotherapy. Strahlenther Onkol 2003;179:175-80.
38. Semiglazov VF, Topuzov EE, Bavli JL, et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994;5:591-5.
39. Skinner KA, Dunnington G, Silberman H, et al. Preoperative 5-fluorouracil and radiation therapy for locally advanced breast cancer. Am J Surg 1997;174:705-8.
40. Skinner KA, Silberman H, Florentine B, et al. Preoperative paclitaxel and radiotherapy for locally advanced breast cancer: surgical aspects. Ann Surg Oncol 1999;7:145-9.
41. Strnad V, Ott O, Potter R, et al. Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy 2004;3:115-9.
42. Swain SM, Sorace RA, Bagley M, et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987;47:3889-94.
43. Toubol E, Buffat L, LeFranc JP, et al. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 1996;34:1175-7.
44. Veronesi U, Bonadonna G, Zurrida S, et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 1995;222: 612-8.
45. Vicini F, Kini VR, Chen P, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early stage breast cancer treated with breast conserving therapy. J Surg Oncol 1999;70:33-40.
46. Vicini FA, Chen PY, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early stage breast cancer treated with breast conserving therapy: preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys 1997;38:301-10.